Insiders · ALNY

John Maraganore

Officer, Director at Alnylam Pharmaceuticals, Inc. (ALNY)

John Maraganore has filed 29 insider reports with the SEC since February 2021, as director at Takeda Pharmaceutical Co Ltd (TAK), director at Kymera Therapeutics, Inc. (KYMR) and director at Rapport Therapeutics, Inc. (RAPP) and at 4 more companies. John Maraganore made no open-market purchases or sales in the last 12 months. The latest filing, on July 6, 2026, reports grant or award and sale back to the company at Takeda Pharmaceutical Co Ltd (TAK).

Filings
29
Companies
7
Bought on market
None
Sold on market
$17.6M

Companies where John Maraganore is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Takeda Pharmaceutical Co Ltd logo
TAK
Takeda Pharmaceutical Co Ltd
Director10,400$21.77Jul 6, 2026
Kymera Therapeutics, Inc. logo
KYMR
Kymera Therapeutics, Inc.
Directorsince January 2022$115.31Jun 25, 2026
Rapport Therapeutics, Inc. logo
RAPP
Rapport Therapeutics, Inc.
Director$23.16Jun 10, 2026
Beam Therapeutics Inc. logo
BEAM
Beam Therapeutics Inc.
Directorsince November 2021$20.90Jun 5, 2026
Prokidney Corp. logo
PROK
Prokidney Corp.
Directorsince July 2022$1.04Jul 3, 2023
Agios Pharmaceuticals, Inc. logo
AGIO
Agios Pharmaceuticals, Inc.
Director28,528$27.60Feb 3, 2023
Alnylam Pharmaceuticals, Inc. logo
ALNY
Alnylam Pharmaceuticals, Inc.
Officer, Director227,663$17.6M$143.82Dec 23, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Also sits on boards with

Officers and directors who share two or more companies with John Maraganore.

Compare John Maraganore with

Other insiders at the same companies

Questions about John Maraganore

What is John Maraganore's role at Alnylam Pharmaceuticals, Inc.?
John Maraganore reports to the SEC as officer and director at Alnylam Pharmaceuticals, Inc. (ALNY), according to the latest filing on December 23, 2021. John Maraganore has also filed as director at Takeda Pharmaceutical Co Ltd (TAK), director at Kymera Therapeutics, Inc. (KYMR), director at Rapport Therapeutics, Inc. (RAPP) and director at Beam Therapeutics Inc. (BEAM).
How many shares does John Maraganore own?
After the latest filing that states it, John Maraganore directly owned 10,400 shares of Takeda Pharmaceutical Co Ltd (TAK), 28,528 shares of Agios Pharmaceuticals, Inc. (AGIO) and 227,663 shares of Alnylam Pharmaceuticals, Inc. (ALNY). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has John Maraganore bought or sold stock recently?
The most recent open-market sale was on November 12, 2021: sold 33,978 shares of Alnylam Pharmaceuticals, Inc. (ALNY) for $5.83M at an average of $171.52.
How do I get alerts when John Maraganore files?
Follow John Maraganore on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by John Maraganore (SEC CIK 0001180432). Totals count each trade once, skipping amendments whose original is on file, from Feb 26, 2021 on. View on SEC EDGAR · Get this as JSON